JR
Insider
Jason P Rhodes
DirectorJason P Rhodes (Director) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales, 1 filed past the two-business-day deadline), most often in Dyne Therapeutics, Inc. (DYN). The largest single filing was $65.2M of DYN (2,586,928 sh across 6 lots, as filed), executed Aug 13.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
8
0 buys · 8 sells · 1 late
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$128.7M
shares × price, as filed
Last traded
Aug 14
Filed Aug 17
Median ADV $59.6M across their filed names
Open performance→Volume by month
Buys $0
Sells $128.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
8 filings
Sector per market data · by filing · past 12 months
Most traded names
DYNRecent filings
DYNSALE
Dyne Therapeutics, Inc.
View filing →
$65.2M2,586,928 sh across 6 lots
Exec Aug 13
Filed Aug 17 · 5:30 PM ET DYNSALE Dyne Therapeutics, Inc. View filing → $17.9M
777,451 sh across 10 lots
Exec Jul 6
Filed Jul 8 · 5:35 PM ET DYNSALE Dyne Therapeutics, Inc. View filing → $10.7M
504,695 sh across 6 lots
Exec Jun 26
Filed Jun 30 · 5:30 PM ET DYNSALE Dyne Therapeutics, Inc. View filing → $5.6M
267,760 sh across 9 lots
Exec Jun 23
Filed Jun 26 · 5:30 PM ET † DYNSALE Dyne Therapeutics, Inc. View filing → $1.7M
95,113 sh across 5 lots
Exec May 4
Filed May 6 · 5:30 PM ET DYNSALE Dyne Therapeutics, Inc. View filing → $4.2M
226,067 sh across 3 lots
Exec Apr 28
Filed Apr 30 · 5:30 PM ET DYNSALE Dyne Therapeutics, Inc. View filing → $7.1M
382,568 sh across 9 lots
Exec Apr 23
Filed Apr 27 · 5:30 PM ET DYNSALE Dyne Therapeutics, Inc. View filing → $16.3M
827,099 sh across 9 lots
Exec Apr 20
Filed Apr 22 · 5:30 PM ET